Gerard Morton, MD, FABS

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Gerard Morton, MD, FABS, is a radiation oncologist at the Sunnybrook Health Sciences Centre, and affiliate scientist of Evaluative Clinical Sciences for the Odette Cancer Research Program at Sunnybrook Research Institute. He is president of the Canadian Brachytherapy Group. Dr. Morton is also a professor of Radiation Oncology at the University of Ontario, and a board member of the Canadian Association of Research Oncology. He is on the editorial board of the Brachytherapy journal. He has made significant contributions to protocols in brachytherapy and radiotherapy for the treatment of prostate cancer, and has contributed more than 100 peer-reviewed publications, including Practical Radiation Oncology, Radiotherapy and Oncology, and the Canadian Urological Association journal . He completed his MB, BcH, and BAO from the National University of Ireland, Medicine in 1985, followed by his FRCPC in Radiation Oncology in 1994. In 1994, he began at the Odette Cancer Center at the University of Toronto as a staff Radiation Oncologist. He became an associate professor in 2011, and in 2020 became a full professor.

Disclosures:

Talks by Gerard Morton, MD, FABS

Prostate High Dose-Rate (HDR) Brachytherapy as Boost and Monotherapy

Posted by Gerard Morton, MD, FABS | Aug 2022

In a 15-minute presentation that is the twelfth in a series of lectures from a special course on brachytherapy for prostate cancer from the American Brachytherapy Society (ABS) and Grand Rounds in Urology, Gerard Morton, MD, FRCPC, FABS, discusses the differences between HDR and LDR brachytherapy, how HDR brachytherapy is performed, and how to select patients for HDR.

Gerard Morton, MD, FABS

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Talks by Gerard Morton, MD, FABS

Prostate High Dose-Rate (HDR) Brachytherapy as Boost and Monotherapy

Join the GRU Community

You have Successfully Subscribed!